Invivyd (IVVD) Operating Expenses (2021 - 2025)

Invivyd (IVVD) reported Operating Expenses of $29.8 million for Q4 2025, down 9.95% on a YoY basis from $33.0 million in Q4 2024, and up 23.23% quarter-over-quarter from $24.2 million in Q3 2025.

Invivyd (IVVD) Operating Expenses (2021 - 2025) Analysis & Trends

Invivyd has reported Operating Expenses for 5 years, with the latest figure at $29.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses fell 9.95% year-over-year to $29.8 million; the trailing twelve-month figure through Dec 2025 stood at $109.0 million (down 46.12% YoY), and the FY2025 full-year result was $109.0 million, down 46.12% from the prior year.
  • Operating Expenses for Q4 2025 stood at $29.8 million, up from $24.2 million in the prior quarter.
  • The five-year high for Operating Expenses was $100.7 million in Q1 2022, with the low at $24.2 million in Q3 2025.
  • Historically, Operating Expenses has averaged $49.9 million across 5 years, with a median of $46.7 million in 2022.
  • Annual changes were most pronounced in 2022 — Operating Expenses soared 160.25% — and 2025, when it slumped 66.27%.
  • Invivyd's Operating Expenses stood at $83.1 million in 2021, then plunged by 41.98% to $48.2 million in 2022, then surged by 59.2% to $76.8 million in 2023, then plunged by 56.94% to $33.0 million in 2024, then dropped by 9.95% to $29.8 million in 2025.
  • The last three Operating Expenses figures came in at $29.8 million (Q4 2025), $24.2 million (Q3 2025), and $26.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.33 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -138.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 574,669.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.85 Bn
9 Abivax 91.96 Bn 91.96 Bn - -67.40 Mn
10 Invivyd 168.41 Mn -58.28 Mn - 29.76 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 29.76 Mn
Sep 30, 2025 24.15 Mn
Jun 30, 2025 26.85 Mn
Mar 31, 2025 28.23 Mn
Dec 31, 2024 33.05 Mn
Sep 30, 2024 71.61 Mn
Jun 30, 2024 51.51 Mn
Mar 31, 2024 46.09 Mn
Dec 31, 2023 76.75 Mn
Sep 30, 2023 43.06 Mn
Jun 30, 2023 53.88 Mn
Mar 31, 2023 39.07 Mn
Dec 31, 2022 48.21 Mn
Sep 30, 2022 47.33 Mn
Jun 30, 2022 51.75 Mn
Mar 31, 2022 100.74 Mn
Dec 31, 2021 83.09 Mn
Sep 30, 2021 60.42 Mn
Jun 30, 2021 44.69 Mn
Mar 31, 2021 38.71 Mn